Search Articles

View query in Help articles search

Search Results (1 to 3 of 3 Results)

Download search results: CSV END BibTex RIS


Geographical Disparities in HIV Seroprevalence Among Men Who Have Sex with Men and People Who Inject Drugs in Nigeria: Exploratory Spatial Data Analysis

Geographical Disparities in HIV Seroprevalence Among Men Who Have Sex with Men and People Who Inject Drugs in Nigeria: Exploratory Spatial Data Analysis

Middle-aged PWID (25-49 years old) had the highest HIV seroprevalence (905/6203, 14.58%,) over other PWID age groups. HIV seroprevalence among female PWID was twice as high as that among male PWID (female: 467/2485, 18.79%; male 659/6989, 9.42%). Female PWID aged 25-49 years had the highest HIV seroprevalence (345/1399, 24.66%,), while the seroprevalence among male PWID in the same age group was 11.65% (560/4804; Table 1).

Amobi Onovo, Abiye Kalaiwo, Moses Katbi, Otse Ogorry, Antoine Jaquet, Olivia Keiser

JMIR Public Health Surveill 2021;7(5):e19587

Epidemiology of Hepatitis C Virus Among People Who Inject Drugs: Protocol for a Systematic Review and Meta-Analysis

Epidemiology of Hepatitis C Virus Among People Who Inject Drugs: Protocol for a Systematic Review and Meta-Analysis

Hepatitis C virus (HCV) is a persistent epidemic among people who inject drugs (PWID), and PWID remain as the population experiencing the most significant impact of HCV-related morbidity and mortality worldwide [1]. In countries where infection control procedures (which include the systematic screening of blood and blood products) have been implemented, injection drug use is the primary means of HCV transmission [1-2].

Daniel J J Smith, Josh Neurer, Ashly E Jordan, Holly Hagan

JMIR Res Protoc 2017;6(10):e201